Fluvoxamine side effects
Pro Research Analysisby 
Searched over 200M research papers
Side Effects of Fluvoxamine: A Comprehensive Overview
Introduction to Fluvoxamine Side Effects
Fluvoxamine, a selective serotonin reuptake inhibitor (SSRI), is widely used for treating conditions such as major depression and obsessive-compulsive disorder (OCD). While it is generally well-tolerated, fluvoxamine is associated with a range of side effects that can impact patient compliance and quality of life. This article synthesizes findings from multiple studies to provide a detailed overview of the side effects associated with fluvoxamine.
Common Side Effects: Gastrointestinal and Neurological Symptoms
Gastrointestinal Side Effects
Gastrointestinal issues are among the most frequently reported side effects of fluvoxamine. These include nausea, diarrhea, and dyspepsia. Studies have shown that these side effects are generally mild to moderate in severity but can be significant enough to warrant discontinuation in some cases 246. Genetic factors, such as polymorphisms in the 5-HT2A receptor and CYP2D6 genes, have been found to predict the likelihood of experiencing these gastrointestinal side effects, with certain genotypes being at a higher risk .
Neurological Side Effects
Neurological side effects such as headaches, dizziness, and somnolence are also commonly reported. In a comparative study, fluvoxamine was associated with a higher incidence of somnolence and headaches compared to paroxetine . Additionally, fluvoxamine has been linked to rare but severe neurological side effects, including tics and movement disorders like dyskinesia and dystonia .
Activation Adverse Events in Youths
In children and adolescents, fluvoxamine has been associated with activation cluster adverse events (AC-AEs), which include symptoms like hyperactivity, activation, and disinhibition. These side effects were observed in 45% of youths treated with fluvoxamine for anxiety disorders, compared to only 4% in the placebo group. The onset of these symptoms typically occurred within the first four weeks of treatment and was correlated with higher blood levels of the drug .
Rare and Severe Side Effects
Serotonin Syndrome and Psychosis-like Symptoms
Although rare, fluvoxamine can induce serotonin syndrome, a potentially life-threatening condition characterized by symptoms such as agitation, confusion, and incoherent thoughts. In a study involving 200 inpatients, no full-blown cases of serotonin syndrome were reported, but some patients did experience reversible changes in mental status .
Sexual Dysfunction
Sexual side effects, including decreased libido and ejaculatory abnormalities, have also been reported, particularly among male patients. These side effects are generally mild but can significantly impact the quality of life and treatment adherence .
Conclusion
Fluvoxamine is an effective SSRI for treating major depression and OCD, but it comes with a range of side effects that can affect patient compliance. Gastrointestinal and neurological symptoms are the most common, while rare but severe side effects like serotonin syndrome and movement disorders also exist. Understanding these side effects and their potential genetic predictors can help clinicians better manage and mitigate these risks, ensuring a more tailored and effective treatment approach.
Sources and full results
Most relevant research papers on this topic
Activation Adverse Events Induced by the Selective Serotonin Reuptake Inhibitor Fluvoxamine in Children and Adolescents
Activation cluster adverse events (AC-AEs) are common side effects of fluvoxamine in children and adolescents, often appearing during the first 8 weeks of treatment, and are associated with higher fluvoxamine blood levels.
A double-blind comparison of fluvoxamine, imipramine and placebo in depressed patients.
Fluvoxamine and imipramine both show anti-depressant effects, with fluvoxamine showing more effects in non-situational depressives and imipramine more effective in retarded depressives.
Efficacy, tolerability and side-effect profile of fluvoxamine for major depression: meta-analysis
Fluvoxamine shows no significant differences in efficacy and tolerability for treating major depression compared to other antidepressants, but has different side effect profiles compared to tricyclics.
Fluvoxamine
Fluvoxamine is an effective and well-tolerated antidepressant alternative to older agents, particularly beneficial for potentially suicidal patients with severe depression, those with underlying compulsive personality disorders, and the elderly.
A double-blind, placebo-controlled trial of fluvoxamine versus imipramine in outpatients with major depression.
Fluvoxamine is superior to placebo in treating moderate major depression, but not to imipramine, with nausea and hyperarousal as common side effects.
Fluvoxamine open-label treatment of adolescent inpatients with obsessive-compulsive disorder or depression.
Fluvoxamine is a relatively safe short-term treatment for adolescents with obsessive-compulsive disorder and may be effective for depression and bulimia.
The serotonin syndrome and psychosis-like side-effects of fluvoxamine clinical use--an estimation of incidence.
Fluvoxamine treatment does not cause potentially lethal serotonin syndrome, but psychosis-like syndromes may occur at a rate of 0.006-0.04 per 100 treatment days.
DOI